| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.771 | 0.004 | 0.771 | 5 Hydroxytryptamine release stimulant | |||
| 0.623 | 0.033 | 0.623 | Caspase 9 stimulant | |||
| 0.575 | 0.01 | 0.575 | GABA C receptor rho-3 antagonist | |||
| 0.542 | 0.015 | 0.542 | Calcium channel L-type activator | |||
| 0.48 | 0.004 | 0.48 | Tyrosine 3 hydroxylase inhibitor | 0.295 0.036 CID_154699713 | ||
| 0.47 | 0.035 | 0.47 | Vasodilator, peripheral | |||
| 0.439 | 0.041 | 0.439 | Aldehyde oxidase inhibitor | |||
| 0.397 | 0.005 | 0.397 | GABA C receptor agonist | |||
| 0.407 | 0.022 | 0.407 | Calcium channel activator | |||
| 0.436 | 0.058 | 0.436 | 5 Hydroxytryptamine release inhibitor | |||
| 0.442 | 0.067 | 0.442 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.379 | 0.004 | 0.379 | Potassium channel (Ca-activated) blocker | |||
| 0.384 | 0.017 | 0.384 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.365 | 0.004 | 0.365 | GABA C receptor rho-2 antagonist | |||
| 0.363 | 0.029 | 0.363 | Psychostimulant | |||
| 0.318 | 0.004 | 0.318 | GABA C receptor antagonist | |||
| 0.346 | 0.037 | 0.346 | Superoxide dismutase inhibitor | 0.333 0.04 CID_154699713 | ||
| 0.315 | 0.008 | 0.315 | 5 Hydroxytryptamine agonist | |||
| 0.328 | 0.032 | 0.708 | Peroxidase inhibitor | 0.708 0.003 CID_154699713 | CID_154699713 | |
| 0.284 | 0.004 | 0.284 | GABA C receptor rho-1 antagonist | |||
| 0.308 | 0.031 | 0.308 | ErbB-1 antagonist | |||
| 0.294 | 0.018 | 0.294 | Focal adhesion kinase 2 inhibitor | |||
| 0.308 | 0.039 | 0.308 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.36 | 0.095 | 0.406 | Histamine release inhibitor | 0.406 0.073 CID_154699713 | CID_154699713 | |
| 0.314 | 0.052 | 0.314 | DNA damaging | |||
| 0.294 | 0.034 | 0.294 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.289 | 0.041 | 0.289 | Gastrin inhibitor | 0.186 0.17 CID_154699713 | ||
| 0.281 | 0.036 | 0.281 | RNA-directed DNA polymerase inhibitor | |||
| 0.254 | 0.014 | 0.254 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.257 | 0.024 | 0.257 | Tubulin antagonist | |||
| 0.311 | 0.079 | 0.311 | Vasodilator, coronary | |||
| 0.259 | 0.028 | 0.259 | Tumour necrosis factor antagonist | |||
| 0.232 | 0.017 | 0.232 | Alpha 2b adrenoreceptor antagonist | |||
| 0.246 | 0.035 | 0.246 | Nitric-oxide synthase stimulant | |||
| 0.234 | 0.024 | 0.234 | Toll-Like receptor 9 antagonist | |||
| 0.229 | 0.022 | 0.229 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.277 | 0.074 | 0.377 | Insulysin inhibitor | 0.377 0.026 CID_154699713 | CID_154699713 | |
| 0.21 | 0.01 | 0.21 | Adenylate cyclase stimulant | 0.152 0.06 CID_154699713 | ||
| 0.256 | 0.058 | 0.256 | Antimitotic | |||
| 0.289 | 0.096 | 0.453 | Antithrombotic | 0.453 0.037 CID_154699713 | CID_154699713 | |
| 0.202 | 0.014 | 0.202 | Alpha 2a adrenoreceptor antagonist | |||
| 0.213 | 0.027 | 0.213 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.221 | 0.038 | 0.221 | Cholinergic | |||
| 0.214 | 0.03 | 0.214 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.218 | 0.035 | 0.218 | Protein kinase stimulant | |||
| 0.198 | 0.016 | 0.198 | 5 Hydroxytryptamine 3A agonist | |||
| 0.234 | 0.054 | 0.234 | DNA methyltransferase I inhibitor | |||
| 0.247 | 0.068 | 0.247 | DNA synthesis inhibitor | |||
| 0.186 | 0.007 | 0.186 | MAP-kinase-activated kinase inhibitor | |||
| 0.235 | 0.057 | 0.235 | DNA methylase inhibitor | |||
| 0.195 | 0.018 | 0.195 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.252 | 0.077 | 0.252 | Interleukin agonist | 0.25 0.079 CID_154699713 | ||
| 0.178 | 0.004 | 0.178 | 5 Hydroxytryptamine 2C agonist | |||
| 0.193 | 0.019 | 0.193 | Alpha 2c adrenoreceptor antagonist | |||
| 0.191 | 0.019 | 0.191 | Alpha 2 adrenoreceptor antagonist | |||
| 0.233 | 0.062 | 0.233 | MAP kinase kinase 2 inhibitor | |||
| 0.178 | 0.011 | 0.178 | Alpha adrenoreceptor agonist | |||
| 0.172 | 0.006 | 0.172 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.221 | 0.058 | 0.221 | Neurotrophic factor enhancer | |||
| 0.177 | 0.015 | 0.177 | Creatine kinase inhibitor | |||
| 0.2 | 0.042 | 0.2 | Lipid peroxidase inhibitor | 0.182 0.049 CID_154699713 | ||
| 0.172 | 0.015 | 0.172 | Prolactin inhibitor | |||
| 0.162 | 0.005 | 0.162 | Alpha 2 adrenoreceptor agonist | |||
| 0.217 | 0.06 | 0.217 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.169 | 0.013 | 0.169 | NMDA 2 receptor antagonist | |||
| 0.222 | 0.067 | 0.222 | Amyloid beta aggregation inhibitor | |||
| 0.175 | 0.023 | 0.175 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.314 | 0.163 | 0.613 | Apoptosis agonist | 0.613 0.046 CID_154699713 | CID_154699713 | |
| 0.169 | 0.019 | 0.169 | NMDA receptor antagonist | |||
| 0.243 | 0.094 | 0.243 | Spasmolytic | |||
| 0.2 | 0.052 | 0.2 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.181 | 0.033 | 0.25 | Toll-Like receptor 2 antagonist | 0.25 0.009 CID_154699713 | CID_154699713 | |
| 0.209 | 0.063 | 0.209 | I kappa B kinase epsilon inhibitor | |||
| 0.286 | 0.14 | 0.286 | 15-Lipoxygenase inhibitor | |||
| 0.161 | 0.015 | 0.161 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.15 | 0.005 | 0.15 | 5 Hydroxytryptamine 2 agonist | |||
| 0.151 | 0.007 | 0.151 | Androgen agonist | |||
| 0.199 | 0.057 | 0.199 | Lipocortins synthesis antagonist | |||
| 0.18 | 0.039 | 0.18 | Toll-Like receptor antagonist | |||
| 0.18 | 0.04 | 0.18 | Acetylcholinesterase inhibitor | |||
| 0.213 | 0.072 | 0.213 | Platelet aggregation inhibitor | |||
| 0.245 | 0.106 | 0.245 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.182 | 0.051 | 0.182 | Amylase inhibitor | |||
| 0.163 | 0.032 | 0.163 | Microtubule formation inhibitor | |||
| 0.254 | 0.124 | 0.342 | Apoptosis antagonist | 0.342 0.06 CID_154699713 | CID_154699713 | |
| 0.161 | 0.032 | 0.171 | Chelator | 0.171 0.03 CID_154699713 | CID_154699713 | |
| 0.188 | 0.059 | 0.188 | Succinate dehydrogenase inhibitor | |||
| 0.166 | 0.039 | 0.166 | Alkylator | |||
| 0.169 | 0.042 | 0.169 | 5 Hydroxytryptamine antagonist | |||
| 0.171 | 0.044 | 0.171 | NADPH oxidase inhibitor | |||
| 0.132 | 0.005 | 0.132 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.131 | 0.005 | 0.131 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.148 | 0.023 | 0.148 | Androgen antagonist | |||
| 0.129 | 0.005 | 0.129 | 5 Hydroxytryptamine 7 agonist | |||
| 0.212 | 0.089 | 0.212 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.239 | 0.117 | 0.239 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.128 | 0.008 | 0.128 | 5 Hydroxytryptamine 2A agonist | |||
| 0.132 | 0.012 | 0.132 | Glycine receptor antagonist | |||
| 0.128 | 0.009 | 0.128 | NMDA 2C receptor antagonist | 0.071 0.032 CID_154699713 | ||
| 0.172 | 0.054 | 0.172 | Heat shock protein 90 antagonist | |||
| 0.169 | 0.052 | 0.169 | MAO inhibitor | |||
| 0.149 | 0.032 | 0.149 | Protein kinase C gamma inhibitor | |||
| 0.153 | 0.036 | 0.153 | Ca2+-transporting ATPase inhibitor | |||
| 0.131 | 0.015 | 0.131 | Beta tubulin antagonist | |||
| 0.152 | 0.037 | 0.152 | Ferrochelatase inhibitor | |||
| 0.179 | 0.065 | 0.179 | MAP kinase kinase 5 inhibitor | |||
| 0.121 | 0.011 | 0.121 | CDC25B inhibitor | |||
| 0.125 | 0.016 | 0.125 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.231 | 0.121 | 0.231 | 12-Lipoxygenase inhibitor | |||
| 0.12 | 0.011 | 0.12 | Acetylcholine M5 receptor agonist | |||
| 0.138 | 0.03 | 0.138 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.172 | 0.065 | 0.172 | Death-associated protein kinase 2 inhibitor | |||
| 0.124 | 0.016 | 0.124 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.136 | 0.03 | 0.136 | DOPA decarboxylase inhibitor | |||
| 0.145 | 0.039 | 0.145 | Alpha adrenoreceptor antagonist | |||
| 0.108 | 0.004 | 0.108 | Dopamine D5 agonist | |||
| 0.169 | 0.066 | 0.169 | Arachidonic acid antagonist | |||
| 0.164 | 0.062 | 0.164 | Acetylcholine M1 receptor antagonist | |||
| 0.155 | 0.053 | 0.155 | MAP3K9 inhibitor | |||
| 0.109 | 0.007 | 0.109 | MAP kinase kinase 7 inhibitor | |||
| 0.14 | 0.039 | 0.14 | TRPA1 agonist | |||
| 0.203 | 0.103 | 0.256 | Vasodilator | 0.256 0.066 CID_154699713 | CID_154699713 | |
| 0.162 | 0.064 | 0.162 | Interferon gamma antagonist | |||
| 0.205 | 0.11 | 0.205 | Neuropeptide Y2 antagonist | |||
| 0.128 | 0.033 | 0.128 | Anabolic | |||
| 0.131 | 0.036 | 0.131 | UDP-glucose 4-epimerase inhibitor | |||
| 0.161 | 0.066 | 0.161 | Hexokinase inhibitor | |||
| 0.186 | 0.094 | 0.186 | Anticonvulsant | |||
| 0.114 | 0.021 | 0.114 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.132 | 0.041 | 0.132 | Antiadrenergic | |||
| 0.112 | 0.022 | 0.112 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.103 | 0.014 | 0.103 | GABA B receptor agonist | |||
| 0.165 | 0.077 | 0.165 | ATPase inhibitor | |||
| 0.14 | 0.052 | 0.14 | Adenylate cyclase inhibitor | 0.134 0.056 CID_154699713 | ||
| 0.215 | 0.127 | 0.215 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.105 | 0.017 | 0.105 | CC chemokine 5 receptor agonist | |||
| 0.134 | 0.046 | 0.134 | Interleukin 8 antagonist | |||
| 0.262 | 0.175 | 0.262 | MAP kinase kinase 6 inhibitor | |||
| 0.128 | 0.041 | 0.128 | Adrenaline antagonist | |||
| 0.144 | 0.061 | 0.144 | Heat shock protein 70 antagonist | |||
| 0.16 | 0.077 | 0.16 | Heat shock protein 90 alpha antagonist | |||
| 0.087 | 0.004 | 0.087 | 5 Hydroxytryptamine 2B agonist | |||
| 0.106 | 0.023 | 0.106 | Dopamine D1 antagonist | |||
| 0.088 | 0.007 | 0.088 | Glutamate (mGluR1a) antagonist | |||
| 0.103 | 0.022 | 0.103 | T cell inhibitor | |||
| 0.16 | 0.079 | 0.175 | Neurotensin receptor agonist | 0.175 0.056 CID_154699713 | CID_154699713 | |
| 0.155 | 0.075 | 0.155 | Melanin inhibitor | |||
| 0.101 | 0.021 | 0.101 | 5 Hydroxytryptamine 1 agonist | |||
| 0.105 | 0.025 | 0.105 | CDC25A inhibitor | |||
| 0.106 | 0.028 | 0.106 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.123 | 0.045 | 0.123 | Butyrylcholinesterase inhibitor | |||
| 0.112 | 0.034 | 0.112 | NADH dehydrogenase inhibitor | |||
| 0.111 | 0.033 | 0.111 | Acetylcholine nicotinic antagonist | |||
| 0.147 | 0.069 | 0.147 | Vascular endothelial growth factor 3 antagonist | |||
| 0.176 | 0.099 | 0.176 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.113 | 0.037 | 0.113 | Triose-phosphate isomerase inhibitor | |||
| 0.135 | 0.059 | 0.135 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.084 | 0.009 | 0.084 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.116 | 0.041 | 0.116 | Nitric-oxide synthase inhibitor | |||
| 0.107 | 0.032 | 0.107 | Inducible nitric-oxide synthase inhibitor | |||
| 0.082 | 0.008 | 0.082 | Ryanodine receptor antagonist | |||
| 0.126 | 0.052 | 0.126 | Topoisomerase I inhibitor | |||
| 0.1 | 0.028 | 0.1 | Dopamine agonist | |||
| 0.103 | 0.031 | 0.474 | Histidine decarboxylase inhibitor | 0.474 0.003 CID_154699713 | CID_154699713 | |
| 0.167 | 0.097 | 0.167 | Anesthetic general | |||
| 0.121 | 0.052 | 0.121 | MAO A inhibitor | |||
| 0.138 | 0.068 | 0.138 | Aurora-C kinase inhibitor | |||
| 0.099 | 0.03 | 0.325 | Glutamate decarboxylase inhibitor | 0.325 0.003 CID_154699713 | CID_154699713 | |
| 0.106 | 0.037 | 0.106 | ALK inhibitor | |||
| 0.218 | 0.15 | 0.218 | Angiogenesis inhibitor | |||
| 0.152 | 0.084 | 0.152 | Sigma receptor agonist | |||
| 0.081 | 0.012 | 0.081 | 5 Hydroxytryptamine 1B agonist | |||
| 0.103 | 0.034 | 0.103 | Alpha 1b adrenoreceptor antagonist | |||
| 0.083 | 0.015 | 0.083 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.086 | 0.018 | 0.086 | NMDA 2A receptor antagonist | 0.075 0.022 CID_154699713 | ||
| 0.142 | 0.075 | 0.142 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.122 | 0.055 | 0.122 | Photosensitizer | |||
| 0.122 | 0.055 | 0.122 | GABA receptor agonist | |||
| 0.181 | 0.114 | 0.269 | Free radical scavenger | 0.269 0.061 CID_154699713 | CID_154699713 | |
| 0.071 | 0.005 | 0.071 | Alpha 1L adrenoreceptor agonist | |||
| 0.143 | 0.077 | 0.143 | MAP kinase kinase 4 inhibitor | |||
| 0.127 | 0.062 | 0.127 | Topoisomerase II inhibitor | |||
| 0.107 | 0.043 | 0.107 | Protein kinase C zeta inhibitor | |||
| 0.105 | 0.041 | 0.105 | Histamine N-methyltransferase inhibitor | |||
| 0.067 | 0.003 | 0.067 | Imidazoline I1 receptor antagonist | |||
| 0.157 | 0.093 | 0.424 | Phospholipase C inhibitor | 0.424 0.009 CID_154699713 | CID_154699713 | |
| 0.078 | 0.014 | 0.078 | Myc inhibitor | |||
| 0.1 | 0.037 | 0.1 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.076 | 0.015 | 0.076 | Dopamine D2 agonist | |||
| 0.112 | 0.051 | 0.112 | Adenylate kinase inhibitor | 0.091 0.084 CID_154699713 | ||
| 0.099 | 0.038 | 0.099 | Adrenaline agonist | |||
| 0.155 | 0.095 | 0.155 | Catenin beta inhibitor | |||
| 0.075 | 0.015 | 0.075 | Prolactin release inhibitor | |||
| 0.097 | 0.037 | 0.097 | Porphobilinogen synthase inhibitor | |||
| 0.089 | 0.03 | 0.089 | Neuronal nicotinic receptor antagonist | |||
| 0.095 | 0.036 | 0.095 | Na+ K+ transporting ATPase inhibitor | |||
| 0.07 | 0.012 | 0.07 | Adenylate cyclase 1 inhibitor | |||
| 0.093 | 0.034 | 0.093 | Acetylcholine M4 receptor antagonist | |||
| 0.074 | 0.016 | 0.074 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.089 | 0.032 | 0.089 | Benzodiazepine agonist | |||
| 0.103 | 0.046 | 0.103 | Antineoplastic alkaloid | |||
| 0.07 | 0.013 | 0.07 | Alpha 1L adrenoreceptor antagonist | |||
| 0.127 | 0.07 | 0.127 | Cyclooxygenase 3 inhibitor | |||
| 0.063 | 0.006 | 0.063 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.213 | 0.157 | 0.263 | Transcription factor NF kappa B inhibitor | 0.263 0.118 CID_154699713 | CID_154699713 | |
| 0.195 | 0.14 | 0.195 | Transcription factor STAT3 inhibitor | |||
| 0.083 | 0.029 | 0.083 | Phospholipase D inhibitor | |||
| 0.075 | 0.021 | 0.075 | 5 Hydroxytryptamine 1A agonist | |||
| 0.097 | 0.044 | 0.097 | Bromodomain-containing protein 2 inhibitor | |||
| 0.094 | 0.042 | 0.094 | Acetylcholine nicotinic agonist | |||
| 0.093 | 0.041 | 0.093 | Dopamine antagonist | |||
| 0.107 | 0.056 | 0.107 | MAO B inhibitor | |||
| 0.171 | 0.12 | 0.171 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.055 | 0.004 | 0.055 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.087 | 0.037 | 0.087 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.156 | 0.107 | 0.156 | Non-steroidal antiinflammatory agent | |||
| 0.094 | 0.046 | 0.094 | Alpha 1 adrenoreceptor antagonist | |||
| 0.074 | 0.027 | 0.074 | Alcohol oxidase inhibitor | |||
| 0.079 | 0.031 | 0.079 | Protein kinase C beta inhibitor | |||
| 0.141 | 0.093 | 0.141 | CF transmembrane conductance regulator agonist | |||
| 0.083 | 0.035 | 0.095 | Phenylalanine 4-hydroxylase inhibitor | 0.095 0.028 CID_154699713 | CID_154699713 | |
| 0.082 | 0.036 | 0.082 | Glycine receptor agonist | |||
| 0.05 | 0.004 | 0.05 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.102 | 0.056 | 0.102 | Glutamate (mGluR7) agonist | |||
| 0.076 | 0.03 | 0.076 | 5 Hydroxytryptamine 3 agonist | |||
| 0.079 | 0.033 | 0.156 | Bcl2 antagonist | 0.156 0.005 CID_154699713 | CID_154699713 | |
| 0.101 | 0.056 | 0.101 | Electrolyte absorption antagonist | |||
| 0.071 | 0.027 | 0.071 | Alpha 1 adrenoreceptor agonist | |||
| 0.051 | 0.007 | 0.051 | Dopamine autoreceptor agonist | |||
| 0.064 | 0.02 | 0.064 | Topoisomerase II beta inhibitor | |||
| 0.126 | 0.082 | 0.126 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.073 | 0.03 | 0.073 | Beta 3 adrenoreceptor antagonist | |||
| 0.07 | 0.028 | 0.07 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.072 | 0.029 | 0.072 | Argininosuccinate synthase inhibitor | |||
| 0.074 | 0.031 | 0.074 | Aromatase inhibitor | |||
| 0.109 | 0.067 | 0.109 | Cystathionine beta-synthase inhibitor | |||
| 0.108 | 0.067 | 0.108 | EphA2 antagonist | |||
| 0.063 | 0.022 | 0.063 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.071 | 0.03 | 0.071 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.054 | 0.014 | 0.054 | Histamine H1 receptor agonist | |||
| 0.107 | 0.067 | 0.107 | DNA intercalator | |||
| 0.078 | 0.04 | 0.078 | Dopamine D2 antagonist | |||
| 0.073 | 0.035 | 0.073 | Dopamine D4 antagonist | |||
| 0.067 | 0.031 | 0.067 | Heat shock protein 90 beta antagonist | |||
| 0.09 | 0.055 | 0.09 | Acetylcholine agonist | |||
| 0.057 | 0.021 | 0.057 | Dopamine D5 antagonist | |||
| 0.056 | 0.021 | 0.056 | NMDA receptor subunit 3B antagonist | |||
| 0.062 | 0.027 | 0.062 | Pregnane X receptor antagonist | |||
| 0.23 | 0.196 | 0.372 | Antibacterial | 0.372 0.09 CID_154699713 | CID_154699713 | |
| 0.098 | 0.064 | 0.098 | Carbonic anhydrase III inhibitor | |||
| 0.163 | 0.13 | 0.163 | Antiamyloidogenic | |||
| 0.124 | 0.091 | 0.124 | Activin receptor-like kinase 2 inhibitor | |||
| 0.081 | 0.048 | 0.081 | Estrogen receptor alpha antagonist | |||
| 0.069 | 0.037 | 0.069 | NMDA receptor glycine site agonist | |||
| 0.12 | 0.087 | 0.15 | Vanilloid 1 agonist | 0.15 0.038 CID_154699713 | CID_154699713 | |
| 0.054 | 0.022 | 0.054 | Phosphodiesterase 3B inhibitor | |||
| 0.069 | 0.038 | 0.069 | Protease 3C (Human rhinovirus) inhibitor | 0.06 0.053 CID_154699713 | ||
| 0.044 | 0.012 | 0.044 | 5 Hydroxytryptamine 1D agonist | |||
| 0.129 | 0.098 | 0.15 | Thiol protease inhibitor | 0.15 0.068 CID_154699713 | CID_154699713 | |
| 0.125 | 0.093 | 0.125 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.07 | 0.039 | 0.07 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.05 | 0.019 | 0.05 | GABA B receptor antagonist | |||
| 0.13 | 0.1 | 0.13 | Neuropeptide Y1 antagonist | |||
| 0.07 | 0.039 | 0.07 | MDM2 inhibitor | |||
| 0.086 | 0.056 | 0.086 | Myeloperoxidase inhibitor | |||
| 0.105 | 0.075 | 0.105 | Acetylcholine release stimulant | |||
| 0.158 | 0.128 | 0.158 | Histone acetyltransferase inhibitor | |||
| 0.065 | 0.035 | 0.065 | Cyclin D1 inhibitor | |||
| 0.047 | 0.018 | 0.051 | AMPA 4 receptor antagonist | 0.051 0.014 CID_154699713 | CID_154699713 | |
| 0.114 | 0.085 | 0.114 | DNA repair enzyme inhibitor | |||
| 0.05 | 0.022 | 0.05 | Histone deacetylase 8 inhibitor | |||
| 0.046 | 0.018 | 0.046 | Kainate receptor 2 antagonist | |||
| 0.062 | 0.034 | 0.062 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.062 | 0.035 | 0.062 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.082 | 0.055 | 0.082 | Platelet growth factor antagonist | |||
| 0.13 | 0.103 | 0.13 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.04 | 0.014 | 0.04 | Catechol O-methyltransferase inhibitor | |||
| 0.058 | 0.032 | 0.058 | Epithelial sodium channel blocker | |||
| 0.066 | 0.04 | 0.066 | NMDA receptor agonist | |||
| 0.062 | 0.037 | 0.062 | Glutamate (mGluR1) antagonist | |||
| 0.03 | 0.004 | 0.03 | Nicotinic alpha4 receptor agonist | |||
| 0.077 | 0.052 | 0.077 | Keratolytic | |||
| 0.063 | 0.038 | 0.063 | Alpha 1d adrenoreceptor antagonist | |||
| 0.029 | 0.005 | 0.029 | Alpha 2c adrenoreceptor agonist | |||
| 0.057 | 0.032 | 0.057 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.078 | 0.054 | 0.078 | Macrophage migration inhibitory factor inhibitor | |||
| 0.036 | 0.012 | 0.036 | Elastase 3A inhibitor | |||
| 0.036 | 0.012 | 0.036 | Elastase 2B inhibitor | |||
| 0.036 | 0.012 | 0.036 | Elastase 3B inhibitor | |||
| 0.061 | 0.038 | 0.061 | Phosphodiesterase 1A inhibitor | |||
| 0.054 | 0.031 | 0.054 | Beta 2 adrenoreceptor antagonist | |||
| 0.063 | 0.04 | 0.063 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.075 | 0.053 | 0.075 | CYP2A6 inhibitor | |||
| 0.084 | 0.062 | 0.084 | Insulin growth factor antagonist | |||
| 0.184 | 0.162 | 0.184 | Transcription factor STAT inhibitor | |||
| 0.072 | 0.05 | 0.072 | Alpha 1a adrenoreceptor antagonist | |||
| 0.059 | 0.037 | 0.059 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.044 | 0.023 | 0.044 | NMDA receptor subunit 3A antagonist | |||
| 0.073 | 0.052 | 0.073 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.068 | 0.047 | 0.068 | Cyclin B3 inhibitor | |||
| 0.05 | 0.03 | 0.05 | Dopamine beta hydroxylase inhibitor | |||
| 0.091 | 0.071 | 0.091 | Sphingomyelinase inhibitor | |||
| 0.042 | 0.022 | 0.042 | 5-Alpha-reductase inhibitor | |||
| 0.085 | 0.066 | 0.085 | Phosphodiesterase I inhibitor | |||
| 0.082 | 0.063 | 0.082 | D-Ala-D-Ala ligase inhibitor | |||
| 0.08 | 0.061 | 0.08 | Caspase 7 inhibitor | |||
| 0.051 | 0.032 | 0.051 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.127 | 0.108 | 0.127 | Pregnane X receptor agonist | |||
| 0.032 | 0.014 | 0.032 | 5 Hydroxytryptamine 6 agonist | |||
| 0.022 | 0.004 | 0.022 | Imidazoline I2 receptor antagonist | |||
| 0.102 | 0.084 | 0.102 | DNA polymerase I inhibitor | |||
| 0.08 | 0.061 | 0.08 | Insulin like growth factor 1 antagonist | |||
| 0.056 | 0.039 | 0.056 | Beta 1 adrenoreceptor antagonist | |||
| 0.061 | 0.044 | 0.061 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.117 | 0.101 | 0.117 | Nav1.6 sodium channel blocker | |||
| 0.019 | 0.003 | 0.019 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | |||
| 0.025 | 0.01 | 0.025 | 5-Alpha-reductase 2 inhibitor | |||
| 0.086 | 0.071 | 0.086 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.14 | 0.125 | 0.14 | Pyruvate kinase inhibitor | |||
| 0.076 | 0.062 | 0.076 | Phosphodiesterase 3A inhibitor | |||
| 0.028 | 0.014 | 0.028 | NMDA receptor glycine site antagonist | |||
| 0.077 | 0.063 | 0.077 | Acetylcholine M3 receptor agonist | |||
| 0.086 | 0.072 | 0.086 | Glutamate release inhibitor | |||
| 0.072 | 0.059 | 0.072 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.051 | 0.039 | 0.051 | Alpha tubulin antagonist | |||
| 0.064 | 0.052 | 0.064 | Check point kinase 1 inhibitor | |||
| 0.052 | 0.04 | 0.052 | Acetylcholine muscarinic agonist | |||
| 0.058 | 0.047 | 0.058 | Adrenaline uptake inhibitor | |||
| 0.046 | 0.034 | 0.046 | CC chemokine 4 receptor antagonist | |||
| 0.047 | 0.036 | 0.047 | Histamine H4 receptor antagonist | |||
| 0.089 | 0.077 | 0.089 | Bile acid receptor antagonist | |||
| 0.021 | 0.01 | 0.021 | Alpha 2b adrenoreceptor agonist | |||
| 0.021 | 0.01 | 0.021 | 5-Alpha-reductase 1 inhibitor | |||
| 0.046 | 0.036 | 0.046 | Cholesterol esterase inhibitor | |||
| 0.062 | 0.051 | 0.062 | Beta adrenoreceptor antagonist | |||
| 0.067 | 0.056 | 0.067 | Telomerase inhibitor | |||
| 0.05 | 0.039 | 0.05 | Aconitate hydratase inhibitor | |||
| 0.071 | 0.061 | 0.071 | Focal adhesion kinase 1 inhibitor | |||
| 0.042 | 0.032 | 0.042 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.036 | 0.026 | 0.036 | Somatostatin 4 agonist | |||
| 0.042 | 0.032 | 0.042 | Nerve growth factor antagonist | |||
| 0.082 | 0.072 | 0.082 | Potassium channel activator | |||
| 0.055 | 0.046 | 0.055 | Biliverdin reductase inhibitor | |||
| 0.053 | 0.043 | 0.053 | Dihydroorotate oxidase inhibitor | |||
| 0.041 | 0.032 | 0.041 | Guanylate cyclase inhibitor | |||
| 0.037 | 0.029 | 0.037 | Alpha 1d adrenoreceptor agonist | |||
| 0.052 | 0.043 | 0.052 | Nicotinic neuronal receptor agonist | |||
| 0.053 | 0.045 | 0.053 | Immunoglobulin Fc receptor antagonist | |||
| 0.057 | 0.049 | 0.057 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.06 | 0.052 | 0.06 | Phosphodiesterase III inhibitor | |||
| 0.013 | 0.006 | 0.013 | Melatonin 2 antagonist | |||
| 0.015 | 0.008 | 0.015 | Melatonin receptor 1A antagonist | |||
| 0.049 | 0.042 | 0.049 | Histamine agonist | |||
| 0.081 | 0.075 | 0.121 | Aminoacyl-tRNA synthetase inhibitor | 0.121 0.029 CID_154699713 | CID_154699713 | |
| 0.076 | 0.071 | 0.076 | GABA A receptor agonist | |||
| 0.063 | 0.058 | 0.063 | Glutamate (mGluR7) antagonist | |||
| 0.087 | 0.083 | 0.087 | Insulin receptor antagonist | |||
| 0.043 | 0.039 | 0.043 | Purinergic P2X4 antagonist | |||
| 0.06 | 0.056 | 0.06 | Phosphofructokinase-1 inhibitor | |||
| 0.076 | 0.073 | 0.076 | Histamine H2 receptor antagonist | |||
| 0.036 | 0.032 | 0.036 | Vascular adhesion protein 1 inhibitor | |||
| 0.039 | 0.036 | 0.039 | Histamine H2 receptor agonist | |||
| 0.033 | 0.031 | 0.033 | Adenosine uptake inhibitor | |||
| 0.037 | 0.035 | 0.037 | Acid-sensing ion channel blocker | |||
| 0.054 | 0.052 | 0.054 | Phosphodiesterase 1B inhibitor | |||
| 0.1 | 0.098 | 0.1 | Aldehyde dehydrogenase inhibitor | |||
| 0.083 | 0.082 | 0.083 | Potassium channel (Voltage-sensitive) activator | |||
| 0.035 | 0.034 | 0.035 | Potassium channel Kv1.1 blocker | |||
| 0.025 | 0.025 | 0.029 | AMPA 3 receptor antagonist | 0.029 0.021 CID_154699713 | CID_154699713 | |
| 0.064 | 0.067 | 0.106 | Glutamate dehydrogenase inhibitor | 0.106 0.028 CID_154699713 | CID_154699713 | |
| 0.062 | 0.066 | 0.12 | Aminopeptidase I inhibitor | 0.12 0.019 CID_154699713 | CID_154699713 | |
| 0.186 | 0.192 | 0.723 | Caspase 3 stimulant | 0.723 0.005 CID_154699713 | CID_154699713 | |
| 0.154 | 0.161 | 0.252 | Antioxidant | 0.252 0.082 CID_154699713 | CID_154699713 | |
| 0.031 | 0.04 | 0.039 | Kainate receptor antagonist | 0.039 0.03 CID_154699713 | CID_154699713 | |
| 0.026 | 0.036 | 0.062 | Arginase inhibitor | 0.062 0.01 CID_154699713 | CID_154699713 | |
| 0.117 | 0.127 | 0.315 | Growth hormone agonist | 0.315 0.029 CID_154699713 | CID_154699713 | |
| 0.019 | 0.029 | 0.041 | AMPA 1 receptor antagonist | 0.041 0.014 CID_154699713 | CID_154699713 | |
| 0.018 | 0.036 | 0.034 | Lysine carboxypeptidase inhibitor | 0.034 0.013 CID_154699713 | CID_154699713 | |
| 0.078 | 0.1 | 0.17 | Expectorant | 0.17 0.028 CID_154699713 | CID_154699713 | |
| 0.14 | 0.164 | 0.47 | Immunostimulant | 0.47 0.033 CID_154699713 | CID_154699713 | |
| 0.083 | 0.108 | 0.162 | Mucolytic | 0.162 0.026 CID_154699713 | CID_154699713 | |
| 0.028 | 0.055 | 0.042 | Membrane dipeptidase inhibitor | 0.042 0.024 CID_154699713 | CID_154699713 | |
| 0.061 | 0.09 | 0.077 | Ornithine decarboxylase inhibitor | 0.077 0.071 CID_154699713 | CID_154699713 | |
| 0.13 | 0.161 | 0.185 | Insulin sensitizer | 0.185 0.089 CID_154699713 | CID_154699713 | |
| 0.05 | 0.085 | 0.135 | Bcl-xL inhibitor | 0.135 0.004 CID_154699713 | CID_154699713 | |
| 0.041 | 0.078 | 0.066 | Carbonic anhydrase stimulant | 0.066 0.034 CID_154699713 | CID_154699713 | |
| 0.065 | 0.102 | 0.264 | Aminopeptidase B inhibitor | 0.264 0.011 CID_154699713 | CID_154699713 | |
| 0.084 | 0.128 | 0.15 | Bone formation stimulant | 0.15 0.059 CID_154699713 | CID_154699713 | |
| 0.028 | 0.075 | 0.064 | Ornithine carbamoyltransferase inhibitor | 0.064 0.029 CID_154699713 | CID_154699713 | |
| 0.054 | 0.104 | 0.085 | Metalloproteinase-9 inhibitor | 0.085 0.041 CID_154699713 | CID_154699713 | |
| 0.052 | 0.105 | 0.117 | Metalloproteinase-2 inhibitor | 0.117 0.031 CID_154699713 | CID_154699713 | |
| 0.034 | 0.095 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.04 CID_154699713 | CID_154699713 | |
| 0.02 | 0.082 | 0.136 | Toll-Like receptor 2 agonist | 0.136 0.012 CID_154699713 | CID_154699713 | |
| 0.021 | 0.087 | 0.042 | Growth hormone release inhibitor | 0.042 0.029 CID_154699713 | CID_154699713 | |
| 0.011 | 0.077 | 0.029 | AMPA 2 receptor antagonist | 0.029 0.022 CID_154699713 | CID_154699713 | |
| 0.049 | 0.117 | 0.09 | Somatostatin 1 agonist | 0.09 0.041 CID_154699713 | CID_154699713 | |
| 0.031 | 0.102 | 0.079 | Neutrophil collagenase inhibitor | 0.079 0.032 CID_154699713 | CID_154699713 | |
| 0.118 | 0.19 | 0.343 | Platelet antagonist | 0.343 0.04 CID_154699713 | CID_154699713 | |
| 0.1 | 0.174 | 0.132 | Platelet adhesion inhibitor | 0.132 0.128 CID_154699713 | CID_154699713 | |
| 0.171 | 0.246 | 0.335 | Interleukin 2 agonist | 0.335 0.052 CID_154699713 | CID_154699713 | |
| 0.034 | 0.111 | 0.069 | Matrix metalloproteinase inhibitor | 0.069 0.045 CID_154699713 | CID_154699713 | |
| 0.034 | 0.115 | 0.059 | Bombesin 1 receptor agonist | 0.059 0.042 CID_154699713 | CID_154699713 | |
| 0.064 | 0.147 | 0.137 | Hematopoietic | 0.137 0.017 CID_154699713 | CID_154699713 | |
| 0.016 | 0.123 | 0.08 | Ribonucleoside-diphosphate reductase inhibitor | 0.08 0.025 CID_154699713 | CID_154699713 | |
| 0.015 | 0.124 | 0.081 | Ribonucleotide reductase inhibitor | 0.081 0.026 CID_154699713 | CID_154699713 | |
| 0.018 | 0.131 | 0.047 | Thymidylate synthase inhibitor | 0.047 0.031 CID_154699713 | CID_154699713 | |
| 0.015 | 0.131 | 0.054 | Antimetabolite | 0.054 0.029 CID_154699713 | CID_154699713 | |
| 0.066 | 0.184 | 0.338 | Thrombolytic | 0.338 0.018 CID_154699713 | CID_154699713 | |
| 0.077 | 0.209 | 0.191 | Phospholipase A2 inhibitor | 0.191 0.047 CID_154699713 | CID_154699713 | |
| 0.006 | 0.141 | 0.061 | GP IIb/IIIa receptor antagonist | 0.061 0.027 CID_154699713 | CID_154699713 | |
| 0.014 | 0.157 | 0.062 | Glycine transporter 2 inhibitor | 0.062 0.024 CID_154699713 | CID_154699713 | |
| 0.016 | 0.167 | 0.038 | Cholecystokinin B agonist | 0.038 0.026 CID_154699713 | CID_154699713 | |
| 0.068 | 0.222 | 0.297 | Anticoagulant | 0.297 0.029 CID_154699713 | CID_154699713 | |
| 0.046 | 0.202 | 0.352 | Glutathione S-transferase inhibitor | 0.352 0.002 CID_154699713 | CID_154699713 | |
| 0.047 | 0.209 | 0.097 | Factor XII inhibitor | 0.097 0.04 CID_154699713 | CID_154699713 | |
| 0.062 | 0.233 | 0.1 | Cell adhesion inhibitor | 0.1 0.089 CID_154699713 | CID_154699713 | |
| 0.029 | 0.205 | 0.1 | Thrombin inhibitor | 0.1 0.025 CID_154699713 | CID_154699713 | |
| 0.02 | 0.212 | 0.062 | Aminopeptidase microsomal inhibitor | 0.062 0.038 CID_154699713 | CID_154699713 | |
| 0.024 | 0.216 | 0.07 | Angiotensin-converting enzyme inhibitor | 0.07 0.019 CID_154699713 | CID_154699713 | |
| 0.013 | 0.22 | 0.042 | Aminopeptidase N inhibitor | 0.042 0.039 CID_154699713 | CID_154699713 | |
| 0.116 | 0.342 | 0.413 | Sodium/bile acid cotransporter inhibitor | 0.413 0.013 CID_154699713 | CID_154699713 | |
| 0.054 | 0.298 | 0.191 | Histone deacetylase SIRT1 inhibitor | 0.191 0.034 CID_154699713 | CID_154699713 | |
| 0.046 | 0.291 | 0.084 | Vanilloid agonist | 0.084 0.06 CID_154699713 | CID_154699713 | |
| 0.022 | 0.268 | 0.084 | Sirtuin 1 inhibitor | 0.084 0.032 CID_154699713 | CID_154699713 | |
| 0.017 | 0.282 | 0.039 | Glutamate (mGluR8) antagonist | 0.039 0.018 CID_154699713 | CID_154699713 | |
| 0.031 | 0.303 | 0.09 | Chymotrypsin inhibitor | 0.09 0.043 CID_154699713 | CID_154699713 | |
| 0.009 | 0.281 | 0.043 | Integrin alpha5beta1 antagonist | 0.043 0.025 CID_154699713 | CID_154699713 | |
| 0.029 | 0.313 | 0.06 | Trypsin inhibitor | 0.06 0.048 CID_154699713 | CID_154699713 | |
| 0.022 | 0.326 | 0.054 | Carbonic anhydrase II stimulant | 0.054 0.032 CID_154699713 | CID_154699713 | |
| 0.004 | 0.345 | 0.06 | Leukotriene A4 hydrolase inhibitor | 0.06 0.015 CID_154699713 | CID_154699713 | |
| 0.037 | 0.38 | 0.375 | Angiogenesis stimulant | 0.375 0.026 CID_154699713 | CID_154699713 | |
| 0.097 | 0.453 | 0.278 | Peptidyltransferase inhibitor | 0.278 0.034 CID_154699713 | CID_154699713 | |
| 0.048 | 0.419 | 0.119 | Folate antagonist | 0.119 0.04 CID_154699713 | CID_154699713 | |
| 0.013 | 0.391 | 0.038 | Neurokinin 2 agonist | 0.038 0.034 CID_154699713 | CID_154699713 | |
| 0.014 | 0.408 | 0.06 | Nitric oxide donor | 0.06 0.048 CID_154699713 | CID_154699713 | |
| 0.035 | 0.444 | 0.408 | Interleukin antagonist | 0.408 0.03 CID_154699713 | CID_154699713 | |
| 0.013 | 0.423 | 0.043 | Neurotensin receptor antagonist | 0.043 0.033 CID_154699713 | CID_154699713 | |
| 0.047 | 0.466 | 0.229 | Hepatoprotectant | 0.229 0.05 CID_154699713 | CID_154699713 | |
| 0.008 | 0.43 | 0.038 | Carbonic anhydrase I stimulant | 0.038 0.026 CID_154699713 | CID_154699713 | |
| 0.008 | 0.453 | 0.091 | Glucagon-like peptide 1 agonist | 0.091 0.027 CID_154699713 | CID_154699713 | |
| 0.004 | 0.456 | 0.044 | Complement C3a chemotactic receptor antagonist | 0.044 0.03 CID_154699713 | CID_154699713 | |
| 0.048 | 0.501 | 0.135 | Factor V inhibitor | 0.135 0.027 CID_154699713 | CID_154699713 | |
| 0.015 | 0.506 | 0.114 | Protease inhibitor | 0.114 0.052 CID_154699713 | CID_154699713 | |
| 0.022 | 0.52 | 0.073 | Adenine nucleotide translocase inhibitor | 0.073 0.013 CID_154699713 | CID_154699713 | |
| 0.018 | 0.531 | 0.116 | Histone deacetylase class III inhibitor | 0.116 0.074 CID_154699713 | CID_154699713 | |
| 0.024 | 0.55 | 0.111 | Nav1.4 sodium channel blocker | 0.111 0.061 CID_154699713 | CID_154699713 | |
| 0.004 | 0.534 | 0.032 | Protocollagen prolyl hydroxylase inhibitor | 0.032 0.013 CID_154699713 | CID_154699713 | |
| 0.03 | 0.593 | 0.086 | Transcription factor NF kappa B stimulant | 0.086 0.057 CID_154699713 | CID_154699713 | |
| 0.036 | 0.666 | 0.326 | Immunomodulator | 0.326 0.069 CID_154699713 | CID_154699713 | |
| 0.005 | 0.638 | 0.087 | Selectin antagonist | 0.087 0.033 CID_154699713 | CID_154699713 | |
| 0.01 | 0.668 | 0.04 | Cathepsin F inhibitor | 0.04 0.033 CID_154699713 | CID_154699713 | |
| 0.006 | 0.744 | 0.048 | Erythropoietin receptor agonist | 0.048 0.022 CID_154699713 | CID_154699713 | |
| 0.003 | 0.753 | 0.027 | Bradykinin B2 receptor agonist | 0.027 0.022 CID_154699713 | CID_154699713 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |